News

Focus on Daniel Lenihan, MD

By Jennifer Baudendistel Miller | January 8, 2018
Washington University School of Medicine

Daniel Lenihan, MD, is a cardio-oncologist who specializes in cardiology, heart disease and advanced heart failure/cardiac transplant. His areas of interest include cardiotoxicity of cancer therapy, early phase clinical trials, amyloidosis, cardiomyopathy and cancer survivorship….

News/In the Media

$2 million in cancer research grants awarded by Siteman Investment Program

By Jim Goodwin | January 8, 2018

Research on acute myeloid leukemia and pancreatic cancer are among the nine projects that will benefit from $2 million in new grants announced by Siteman Cancer Center through its Siteman Investment Program. The goal of the grants…

Two people exercise by walking with weights.

In new year, resolve to learn your risks of cancer, type 2 diabetes, other diseases

By Jim Goodwin | January 7, 2018
Washington University School of Medicine

Many cancers and chronic diseases are influenced by lifestyle and can be prevented. But most of us don’t know where to start. As the new year begins, an easy first step is the Your Disease Risk…

Staff/Faculty Update

Aimee James Appointed to Prevention and Control Research Program Co-Leader

By Jennifer Baudendistel Miller | January 6, 2018
Washington University School of Medicine

Aimee James, PhD, MPH, associate professor of surgery in the Division of Public Health Sciences at Washington University School of Medicine, has been appointed as the new Prevention and Control Research Program co-leader for Siteman Cancer…

OncLive

OncLive Strategic Alliance

By Lauren King | December 20, 2017

We partner with OncLive on a series of informative videos about cancer treatment and research. You watch those by clicking the link below. https://www.onclive.com/sap-partner/cancer-centers/siteman

Research

Study prompts new ideas on cancers’ origins

By Jim Dryden | December 18, 2017
Washington University School of Medicine

Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer — a finding that could upend the…

Clinical, News/In the Media

Pursuing a precision paradigm

By Terri Nappier | December 13, 2017

Of the top-grossing domestic movies of 2017 to date, three of the Top 5 feature superheroes: Wonder Woman; Guardians of the Galaxy, Vol. 2; and Spider-Man: Homecoming. Similarly, in 2016, five of the Top 10 movies focus…

Timothy Ley, MD, the Lewis T. and Rosalind B. Apple Professor of Medicine, is a hematologist, oncologist and cancer biologist. For decades, the Ley lab has used mouse models of acute myeloid leukemia to establish key principles of AML pathogenesis. (Photo: James Byard)

News/In the Media, Research, Staff/Faculty Update

Undaunted explorer

By Terri Nappier | December 13, 2017

Timothy Ley, MD, the Lewis T. and Rosalind B. Apple Professor of Medicine, has been investigating leukemia, particularly acute myeloid leukemia (AML), for decades. A glimpse of his research over just the past 10 to 15…

Washington University School of Medicine in St. Louis professors Samuel Achilefu, PhD, David Holtzman, MD, and Eric Leuthardt, MD (left to right, above) have been elected to the National Academy of Inventors.

News/In the Media, Staff/Faculty Update

Medical School faculty named to National Academy of Inventors

By Tamara Bhandari | December 13, 2017
Washington University School of Medicine

Noted innovators Samuel Achilefu, PhD, David Holtzman, MD, and Eric Leuthardt, MD – faculty members at Washington University School of Medicine in St. Louis – have been named fellows of the National Academy of Inventors (NAI). The…

Staff/Faculty Update

Margenthaler elected to surgical society post

By Jim Goodwin | December 12, 2017
Washington University School of Medicine

Julie Margenthaler, MD, a professor of surgery at Washington University School of Medicine in St. Louis and a breast surgeon at Siteman Cancer Center, has been named secretary-treasurer of the American Society of Breast Surgeons….

Previous 1 … 41 42 43 44 45 … 56 Next

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Treatment
Clinical
How Siteman is leading the way in personalized brain tumor treatment
If you or a loved one have recently been diagnosed with a brain tumor, you likely feel a great deal of fear and have many questions. The brain is the epicenter of who we are,...
Read The Full Story

How Siteman is leading the way in personalized brain tumor treatment

Cancer Types

The Siteman Approach

Specialized Programs

Siteman Cancer Center expands proton therapy treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Couple honors physician with gift for distinguished professorship

News

Focus on Daniel Lenihan, MD

$2 million in cancer research grants awarded by Siteman Investment Program

In new year, resolve to learn your risks of cancer, type 2 diabetes, other diseases

Aimee James Appointed to Prevention and Control Research Program Co-Leader

OncLive Strategic Alliance

Study prompts new ideas on cancers’ origins

Pursuing a precision paradigm

Undaunted explorer

Medical School faculty named to National Academy of Inventors

Margenthaler elected to surgical society post

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman Cancer Center ranked No. 10 among U.S. cancer centers

Diversity, Equity & Inclusion at Siteman

How Siteman is leading the way in personalized brain tumor treatment

Cancer Types

The Siteman Approach

Specialized Programs

Siteman Cancer Center expands proton therapy treatment

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman Cancer Center News